Literature DB >> 22140533

Elucidation of the dual role of Mycobacterial MoeZR in molybdenum cofactor biosynthesis and cysteine biosynthesis.

Martin Voss1, Manfred Nimtz, Silke Leimkühler.   

Abstract

The pathway of molybdenum cofactor biosynthesis has been studied in detail by using proteins from Mycobacterium species, which contain several homologs associated with the first steps of Moco biosynthesis. While all Mycobacteria species contain a MoeZR, only some strains have acquired an additional homolog, MoeBR, by horizontal gene transfer. The role of MoeBR and MoeZR was studied in detail for the interaction with the two MoaD-homologs involved in Moco biosynthesis, MoaD1 and MoaD2, in addition to the CysO protein involved in cysteine biosynthesis. We show that both proteins have a role in Moco biosynthesis, while only MoeZR, but not MoeBR, has an additional role in cysteine biosynthesis. MoeZR and MoeBR were able to complement an E. coli moeB mutant strain, but only in conjunction with the Mycobacterial MoaD1 or MoaD2 proteins. Both proteins were able to sulfurate MoaD1 and MoaD2 in vivo, while only MoeZR additionally transferred the sulfur to CysO. Our in vivo studies show that Mycobacteria have acquired several homologs to maintain Moco biosynthesis. MoeZR has a dual role in Moco- and cysteine biosynthesis and is involved in the sulfuration of MoaD and CysO, whereas MoeBR only has a role in Moco biosynthesis, which is not an essential function for Mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22140533      PMCID: PMC3227635          DOI: 10.1371/journal.pone.0028170

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Among the metabolic pathways requiring sulfur transfer are those leading to the formation of FeS clusters, biotin, thiamin, lipoic acid, molybdopterin (MPT), and sulfur-containing bases in RNA [1]. In addition, a new pathway for cysteine biosynthesis involving sulfur transfer has been elucidated in Mycobacterium tuberculosis recently [2], [3]. This pathway involves the ubiquitin-fold protein CysO that contains a C-terminal thiocarboxylate group at the last glycine of a GG-motif as sulfide donor [4]. Similar proteins involved in sulfur transfer are the ThiS protein involved in thiamin biosynthesis [5] and the MoaD protein involved in molybdopterin biosynthesis [6]. The M. tuberculosis protein MoeZR has been shown to transfer sulfur onto CysO for the formation of the thiocarboxylate group. The cysteine synthase M (CysM) catalyzes the addition of O-phosphoserine to the carboxy-terminus of the protein-bound CysO-thiocarboxylate to generate a cysteine-CysO adduct [7]. The protease Mec+ hydrolyzes the CysO-cysteine adduct to release cysteine and regenerate CysO [2]. The CysO activating enzyme MoeZ belongs to a superfamily of proteins consisting of related proteins that are members of pathways involved in the transfer of sulfur-containing moieties to metabolites [8]. Members of this family are referred to as MoeB, MoeBR, MoeZR, MoeZ and MOCS3 [9]. MoeB, the molybdopterin synthase activating enzyme in molybdenum cofactor (Moco) biosynthesis, is the best characterized protein from this family [10]. E. coli MoeB was shown to activate the small subunit of MPT synthase MoaD to form an acyl-adenylate intermediate at its C-terminal glycine [11]. Subsequently, the MoaD acyl-adenylate is converted to a thiocarboxylate either by a L-cysteine desulfurase using L-cysteine as sulfur source [12] or by a rhodanese-like protein containing a protein-bound sulfane sulfur [13]. In all eukaryotic and several bacterial MoeB homologs a rhodanese-like domain is fused to the C-terminus of MoeB (referred to as MoeBR and MoeZR) [9]. This rhodanese-like domain was shown to be directly involved in the generation of the thiocarboxylate group of the MoaD homolog in humans [13]. While all sequenced eukaryotic MoeB-homologs so far contain the C-terminal rhodanese-like domain, the bacterial homologs are much more divergent. Here, either a MoeB-homolog is present, a MoeB-homolog with a C-terminal rhodanese-like domain (MoeBR), a MoeZ-homolog, a MoeZ-homolog with a C-terminal rhodanese-like domain (MoeZR) or a combination of several of these proteins [9]. MoeBR and MoeZR proteins share a high amino acid sequence identity. The main difference between both proteins are two conserved CXXC motifs near the C-terminus of the MoeB-domain. While these two motifs are present in all MoeB and MoeBR proteins, MoeZ and MoeZR homologs are mostly missing the second motif completely, while the first motif comprises the consensus sequence NYRD [9]. Recently, the role of genes involved in Moco biosynthesis were described for M. tuberculosis [14]. While E. coli contains single copies of the genes for Moco biosynthesis, a distinguishing feature of members of the M. tuberculosis complex is their possession of multiple homologs associated with the steps of the Moco biosynthesis pathway for the conversion of GTP to cyclic pyranopterin monophosphate (cPMP), the formation of molybdopterin (MPT) by insertion of two sulfur atoms into cPMP and the final insertion of molybdate to the dithiolene sulfurs of MPT, thus forming Moco [14], [15]. According to our previous nomenclature we refer to the protein for the moeB2 gene as MoeBR and for the protein to the moeB1 gene as MoeZR. A gene region containing moaA1-moaB1-moaC1-moaD1 and moeB2 was acquired by horizontal gene transfer in M. tuberculosis H37Rv and M. bovis BCG [14]. In addition, a moaX gene was identified located downstream of this cluster which comprises a fusion of moaD and moaE and was shown to form active components of MPT synthase, since the moaX gene was able to complement both, a M. smegmatis moaD2 and moaE2 mutant [14]. Previously, the effects of several M. tuberculosis mutants in genes for Moco biosynthesis were described [14]: a M. tuberculosis moeB1 mutant is defective in arresting phagosome maturation [16]; moaC1 and moaX mutants showed a reduced ability to parasitize macrophages [17]; and a moaC1 mutant was attenuated for growth in primate lungs [18]. In addition, the gene expression profile of M. tuberculosis in mice specifically identified moaB2 as part of a gene cluster which was highly expressed in vivo [19]. Most recently, independent transposon mutants in moaC1 and moaD1 in the M. tuberculosis W-Beijing strain, GC1237, were identified by high-content, phenotypic cell-based screening as defective in the ability to arrest phagosome maturation [20]. An important role for nitrate reductase under anaerobic growth conditions has been ascribed for M. tuberculosis [14]. In this study we investigated the role of MoeBR and MoeZR in Moco biosynthesis. Mycobacterial MoeBR and MoeZR were purified and characterized in their activities. Both MoeBR and MoeZR showed thiosulfate∶sulfurtransferase activity. After coexpression of MoeZR and MoeBR with either MoaD1 or MoaD2 in E. coli, sulfurated MoaD-homologs for Moco biosynthesis were obtained. The sulfur-transfer was verified by mass spectrometry. Direct interaction between MoeZR, MoeBR and MoaD1, MoaD2 or CysO were analyzed by copurification studies. Our results show that both MoeBR and MoeZR have a role in Moco biosynthesis. While MoeBR preferentially interacts with both MoaD proteins, MoeZR has a dual role in the cell and is able to transfer the sulfur to either of the two MoaDs or CysO, a protein involved in cysteine biosynthesis.

Results

Test of functional complementation of E. coli moeB cells with MoeBR and MoeZR

To analyze the role of the duplicated E. coli MoeB homologs from M. tuberculosis MoeBR and MoeZR in Moco biosynthesis, functional complementation studies of an E. coli moeB strain were performed. To investigate the functional properties of both proteins, M. tuberculosis MoeBR and MoeZR were cloned into expression vectors (obtained from J. Kuper, EMBL Hamburg), resulting into fusion proteins with an N-terminal MBP-tag. For functional complementation studies, the corresponding vectors were expressed in the E. coli moeB mutant strain (plus 20 µM IPTG). Complementation of the strains by the Mycobacterial proteins would result in the production of active nitrate reductase, a Moco-containing enzyme, the activity of which is dependent on the ability of cells to synthesize Moco. The activity of nitrate reductase can be quantified in crude cell extracts (Table 1). The values in Table 1 show that MoeBR but not MoeZR alone was able to complement the E. coli moeB − strain at least to some extent (6-fold increase in comparison to the background), thus, it is speculated that MoeZR is unable to interact with the E. coli MoaD protein. To circumvent this, a coexpression with the corresponding Mycobacterium homolog would be necessary. For this purpose, we cloned the genes moaD1, moaD2, moaX and additionally cysO from M. bovis total DNA, which is commercially available. The amino acid sequences are identical with the ones of the M. tuberculosis proteins, so the M. bovis sequence should be suitable for protein expression and interaction studies of the purified proteins with M. tuberculosis MoeBR and MoeZR. MoaX is a fusion protein of MoaD and MoaE and was shown before to harbor MPT synthase activity [14]. The genes were cloned into P15A origin based expression vectors which allowed simultaneous replication of two vectors after transformation in the E. coli moeB cells. The results in Table 1 show that in combination with MoaD1 and MoaD2, MoeBR and MoeZR were both able to functionally complement the E. coli moeB strain. The determined nitrate reductase activities for MoeZR were 13–14 fold higher in conjunction with MoaD1 and MoaD2 in comparison to the background, which implies that MoeZR is well able to activate the Mycobacterial MoaD homologs but not MoaD from E. coli. The nitrate reductase activities for the complemented cells with MoeBR in addition to MoaD1 and MoaD2 were 1.9–2.3 increased in comparison to the single complementation with MoeBR, showing that MoeBR better interacts with its own partners. The nitrate reductase activities of MoeZR and MoeBR in conjunction with the MoaD homologs were comparable (Table 1). No functional complementation was obtained by coexpressing MoaX.
Table 1

Nitrate reductase activity after functional complementation of an E. coli moeB strain with the Mycobacterial proteins MoeZR, MoeBR, MoaD1, MoaD2, and CysO.

MoeB-homologa MoaD-homologa Activity [U/OD600]b
moeB -0.003±0.001
MoeB E. coli -0.233±0.033
-MoaD E. coli 0.003±0.006
-MoaD10.011±0.001
-MoaD20.013±0.003
-CysO0.011±0.001
-MoaX0.012±0.001
MoeBR-0.020±0.005 **c , d
MoeBRMoaD10.046±0.009 **d
MoeBRMoaD20.038±0.007 **d
MoeBRCysO0.013±0.002
MoeBRMoaX0.009±0.001
MoeZR-0.003±0.006
MoeZRMoaD10.039±0.007 **e
MoeZRMoaD20.042±0.008 **e
MoeZRCysO0.010±0.004
MoeZRMoaX0.012±0.005

MBP-MoeBR and MBP-MoeZR were coexpressed in an E. coli moeB strain together with His6-MoaD1, His6-MoaD2, His6-MoaX or His6-CysO as indicated.

Nitrate reductase activity was determined in crude cell extracts by a spectroscopic assay using benzyl viologen as described by Jones and Garland [27]. One unit of nitrate reductase activity is described as the production of 1 µmol of nitrite per min per O.D. 600. Assays were performed in triplicate.

Significant differences at a level of P<0.01 (Student's t test) are indicated as **. All values represent means ± standard deviation (SD) for n = 9.

significant difference of the MoeBR complemented strain compared to the E. coli moeB strain.

significant differences of the MoeBR/MoaD1 and MoeBR/MoaD2 complemented strains to the MoeBR complemented E. coli strain.

significant differences of the MoeZR/MoaD1 and MoeZR/MoaD2 complemented strains to the MoeZR complemented E. coli strain.

MBP-MoeBR and MBP-MoeZR were coexpressed in an E. coli moeB strain together with His6-MoaD1, His6-MoaD2, His6-MoaX or His6-CysO as indicated. Nitrate reductase activity was determined in crude cell extracts by a spectroscopic assay using benzyl viologen as described by Jones and Garland [27]. One unit of nitrate reductase activity is described as the production of 1 µmol of nitrite per min per O.D. 600. Assays were performed in triplicate. Significant differences at a level of P<0.01 (Student's t test) are indicated as **. All values represent means ± standard deviation (SD) for n = 9. significant difference of the MoeBR complemented strain compared to the E. coli moeB strain. significant differences of the MoeBR/MoaD1 and MoeBR/MoaD2 complemented strains to the MoeBR complemented E. coli strain. significant differences of the MoeZR/MoaD1 and MoeZR/MoaD2 complemented strains to the MoeZR complemented E. coli strain.

Purification of MoeBR and MoeZR

To further characterize MoeBR and MoeZR, both proteins were purified after heterologous expression in E. coli. For purification of MoeZR and MoeBR, both genes cloned in the pMalC2x vector were used. Expression of the proteins in BL21(DE3) cells resulted in N-terminal MBP-tagged recombinant proteins. MoeZR and MoeBR were purified by amylose affinity chromatography. One major band was visible on SDS-polyacrylamide gels with a size corresponding closely to the calculated molecular masses of the MBP-MoeZR fusion protein of 94 kDa and MBP-MoeBR with a mass of 93 kDa (Figure 1). However, some degradation products are visible on the SDS-polyacrylamide gel. The band at 45 kDa was determined to be MBP, as verified by MALDI peptide mapping. MoeZR and MoeBR were purified with a yield of 4.4 mg/L or 7.8 mg/L E. coli cells. To determine whether structural differences between MoeBR and MoeZR exist, CD spectra of both proteins were recorded. As shown in Fig. 2 the far-ultraviolet CD spectra revealed mainly no differences in the average composition of secondary-structural elements of MoeZR and MoeBR.
Figure 1

Purification of M. tuberculosis MoeZR and MoeBR after heterologous expression in E. coli.

5 µg of the purified proteins were separated by 15% SDS-PAGE and stained with Coomassie Blue. 1: MBP-MoeZR, 2: MBP-MoeBR. The band at 45 kDa in the MoeBR sample was shown to be MBP.

Figure 2

Circular Dichroism (CD) spectroscopy of MoeBR and MoeZR.

CD on purified MBP-MoeBR and MBP_MoeZR were recorded in a 0.1 cm path-length Suprasil quartz cell with a Jasco-J715 CD spectrometer. Far-UV CD was recorded from 260-198 nm using a step size of 1 nm with a signal averaging time of 4 seconds at each wavelength step. 200 µL of MoeBR and MoeZR at a concentration of 0.1 mg/mL was used.

Purification of M. tuberculosis MoeZR and MoeBR after heterologous expression in E. coli.

5 µg of the purified proteins were separated by 15% SDS-PAGE and stained with Coomassie Blue. 1: MBP-MoeZR, 2: MBP-MoeBR. The band at 45 kDa in the MoeBR sample was shown to be MBP.

Circular Dichroism (CD) spectroscopy of MoeBR and MoeZR.

CD on purified MBP-MoeBR and MBP_MoeZR were recorded in a 0.1 cm path-length Suprasil quartz cell with a Jasco-J715 CD spectrometer. Far-UV CD was recorded from 260-198 nm using a step size of 1 nm with a signal averaging time of 4 seconds at each wavelength step. 200 µL of MoeBR and MoeZR at a concentration of 0.1 mg/mL was used.

Analysis of the sulfurtransferase activity of MoeZR and MoeBR

For MoeB-like proteins with a C-terminal rhodanese-like domain, it was shown before that they contain a conserved cysteine residue, which is part of a highly conserved six-amino acid active-site loop, that is essential for thiosulfate sulfurtransferase activity by formation of a persulfide group during catalysis. After purification of MoeBR and MoeZR, it was of interest to compare the activities of the C-terminal rhodanese-like domain of the purified proteins. In vitro, thiosulfate sulfurtransferase activity was measured by the method described by Sörbo [21]. The data in Table 2 show that MoeBR and MoeZR express thiosulfate sulfurtransferase activity. The kcat and KM values for MoeZR and MoeBR with thiosulfate are comparable as revealed by the kcat/KM values, however, the kcat/KM with cyanide is only half for MoeBR in comparison to MoeZR. In total, the kcat values are 112–196 times higher in comparison to human MOCS3 [9] and comparable with yeast Uba4 [22], homologous proteins from eukaryotes.
Table 2

Kinetic parameters of the thiosulfate∶cyanide sulfurtransferase activity of purified MoeBR and MoeZR.

Na2S2O3 a NaCNa
kcat [s−1]KM [mM]kcat/KM [s−1*mM−1]KM [mM]kcat/KM [s−1*mM−1]
MoeZR2.25±0.201.67±0.281.350.81±0.072.78
MoeBR3.92±0.234.19±0.420.943.28±0.121.20

The Thiosulfate∶cyanide sulfurtransferase activity of MBP-MoeZR and MBP-MoeBR were measured by the colorimetric assay after Sörbo [21]. KM and kcat values were determined by varying concentrations of sodium thiosulfate (0.5–60 mM) and potassium cyanide (0.1–40 mM) with 0.5–1 µM enzyme.

The Thiosulfatecyanide sulfurtransferase activity of MBP-MoeZR and MBP-MoeBR were measured by the colorimetric assay after Sörbo [21]. KM and kcat values were determined by varying concentrations of sodium thiosulfate (0.5–60 mM) and potassium cyanide (0.1–40 mM) with 0.5–1 µM enzyme.

Copurification of MoeBR and MoeZR with MoaD1, MoaD2 and CysO

To additionally confirm that MoeZR interacts with MoaD1 and MoaD2, it should be possible to copurify the protein complexes after coexpression in E. coli. Plasmids expressing His6-MoaD1, His6-MoaD2, and His6-CysO were cotransformed with MBP-MoeZR and MBP-MoeBR and subjected to Ni-NTA affinity chromatography after coexpression. The results in Figure 3 show, that with His6-MoaD1, His6-MoaD2 and His6-CysO, MBP-MoeZ was copurified. In contrast, MBP-MoeBR was only copurified in the mixtures containing His6-MoaD1 and His6-MoaD2. Thus, MoeBR does not interact with CysO. The results were additionally confirmed by immunoblot analyses using an MBP-antibody (Figure 3) and in addition by MALDI peptide mapping (data not shown). Both analyses confirmed clearly, that MoeBR does not interact with CysO.
Figure 3

Copurification of MoeBR or MoeZR with MoaD1, MoaD2 and CysO.

MBP-MoeBR and MBP-MoeZR were coexpressed in an E. coli moeB strain together with His6-MoaD1, His6-MoaD2 or His6-CysO and purified by Ni-NTA chromatography afterwards. As control, His6-MoaD1, His6-MoaD2 or His6-CysO were also expressed without MoeBR and MoeZR in the E. coli moeB strain. The proteins were separated by 15% SDS-PAGE and stained with Coomassie Blue or, in addition, the presence of MBP-MoeBR and MBP-MoeZR was determined by immunodetection using polyclonal MBP antisera (Sigma). 1: His6-MoaD1, 2: His6-MoaD2, 3: His6-CysO, 4: His6-MoaD1/MBP-MoeZR, 5: His6-MoaD2/MBP-MoeZR, 6: His6-CysO/MBP-MoeZR, 7: His6-MoaD1/MBP-MoeBR, 8: His6-MoaD2/MBP-MoeBR, 9: His6-CysO/MBP-MoeBR.

Copurification of MoeBR or MoeZR with MoaD1, MoaD2 and CysO.

MBP-MoeBR and MBP-MoeZR were coexpressed in an E. coli moeB strain together with His6-MoaD1, His6-MoaD2 or His6-CysO and purified by Ni-NTA chromatography afterwards. As control, His6-MoaD1, His6-MoaD2 or His6-CysO were also expressed without MoeBR and MoeZR in the E. coli moeB strain. The proteins were separated by 15% SDS-PAGE and stained with Coomassie Blue or, in addition, the presence of MBP-MoeBR and MBP-MoeZR was determined by immunodetection using polyclonal MBP antisera (Sigma). 1: His6-MoaD1, 2: His6-MoaD2, 3: His6-CysO, 4: His6-MoaD1/MBP-MoeZR, 5: His6-MoaD2/MBP-MoeZR, 6: His6-CysO/MBP-MoeZR, 7: His6-MoaD1/MBP-MoeBR, 8: His6-MoaD2/MBP-MoeBR, 9: His6-CysO/MBP-MoeBR.

Electrospray Mass Spectrometry of MoaD1, MoaD2 and CysO after coexpression with MoeBR and MoeZR

To directly prove the existence of a thiocarboxylate group at the C-terminal glycine of either His6-MoaD1, His6-MoaD2 or His6-CysO after coexpression with MBP-MoeBR or MBP-MoeZR, respectively, the purified proteins were subjected to electrospray ionization (ESI) mass spectrometry, which allows the detection of the oxygen versus sulfur exchange due to its characteristic mass shift of 16 Da. As shown in Fig. 4, His6-MoaD1 and His6-MoaD2 contained a C-terminal thiocarboxylate group after coexpression with MBP-MoeBR and MBP-MoeZR. In contrast, on His6-CysO a thiocarboxylate group was only determined when MoeZR was present for coexpression. The presence of the modification at the C-terminal glycine was verified by MS/MS based on differences after carboxyterminal fragmentation analyses (data not shown). This clearly shows that both MoeBR and MoeZR are able to activate MoaD1 and MoaD2, however, only MoeZR is able to form a stable complex with CysO which leads to the formation of the C-terminal thiocarboxylate group on CysO.
Figure 4

Deconvoluted ESI mass spectra of MoaD1, MoaD2, and CysO.

The sulfuration level of His6-MoaD1 (A–C), His6-MoaD2 (D–F) and His6-CysO (G–I) was analyzed after expression in E. coli moeB strain either alone or after coexpression with MBP-MoeZR or MBP-MoeBR. After coexpression, His6-MoaD1, His6-MoaD2 and His6-CysO were purified by Ni-NTA chromatography and subjected to ESI-MS. The mass increase of +16 Da corresponds to the exchange of an oxygen versus a sulfur atom to generate thiocarboxylated proteins. (A) His6-MoaD1, (B) His6-MoaD1 after coexpression with MBP-MoeZ, (C) His6-MoaD1 after coexpression with MBP-MoeBR. (D) His6-MoaD2, (E) His6-MoaD2 after coexpression with MBP-MoeZR, (F) His6-MoaD2 after coexpression with MBP-MoeBR. (G) His6-CysO, (H) His6-CysO after coexpression with MBP-MoeZR, (I) His6-CysO after coexpression with MBP-MoeBR. Additional peaks with mass increments of 22 Da are due to the corresponding Na-salts of proteins.

Deconvoluted ESI mass spectra of MoaD1, MoaD2, and CysO.

The sulfuration level of His6-MoaD1 (A–C), His6-MoaD2 (D–F) and His6-CysO (G–I) was analyzed after expression in E. coli moeB strain either alone or after coexpression with MBP-MoeZR or MBP-MoeBR. After coexpression, His6-MoaD1, His6-MoaD2 and His6-CysO were purified by Ni-NTA chromatography and subjected to ESI-MS. The mass increase of +16 Da corresponds to the exchange of an oxygen versus a sulfur atom to generate thiocarboxylated proteins. (A) His6-MoaD1, (B) His6-MoaD1 after coexpression with MBP-MoeZ, (C) His6-MoaD1 after coexpression with MBP-MoeBR. (D) His6-MoaD2, (E) His6-MoaD2 after coexpression with MBP-MoeZR, (F) His6-MoaD2 after coexpression with MBP-MoeBR. (G) His6-CysO, (H) His6-CysO after coexpression with MBP-MoeZR, (I) His6-CysO after coexpression with MBP-MoeBR. Additional peaks with mass increments of 22 Da are due to the corresponding Na-salts of proteins.

Discussion

Our studies involve the characterization of Mycobacterial MoeZR and MoeBR. A distinguishing feature of members of the M. tuberculosis species is their possession of multiple homologs associated with the first step of Moco biosynthesis [14], [23]. Two homologs of the E. coli MoeB protein were identified in M. tuberculosis H37Rv and M. bovis BCG Pasteur (Table 3). The corresponding genes were annotated as moeB1 and moeB2 [. According to our previous nomenclature we refer to the protein for the moeB2 gene as MoeBR and for the protein to the moeB1 gene as MoeZR, since both proteins contain a C-terminal rhodanese-like domain, which is present in some bacterial and eukaryotic homologs including human MOCS3, but not in E. coli MoeB [9]. For M. tuberculosis MoeZR it was described that it plays a role in a novel cysteine biosynthesis pathway [2]. This cysteine biosynthesis pathway involves a small sulfur carrier protein, CysO, which carries a C-terminal thiocarboxylate group and a cysteine synthase, CysM [4]. CysM reacts with O-phosphoserine to form an α-aminoacrylate intermediate [7]. The sulfur is then provided by CysO and cleavage of cysteine results in the release of carboxylated CysO [3]. For the regeneration of CysO thiocarboxylate, it has been suggested that MoeZR first activates CysO by acyl-adenylation of the C-terminus and then the thiocarboxylate group is formed by involvement of a sulfane sulfur bound to the C-terminal rhodanese-like domain of MoeZR [2]. The sulfur source so far remains unknown. These studies were performed in vitro by using crude cell extracts, in vivo evidence for the involvement of MoeZR in CysO activation was not shown to date. It was only reported, that the expression of MoeZR is upregulated under the same conditions that produce upregulation of CysO and CysM expression, mainly conditions of oxidative stress [3]. Our studies performed in E. coli give direct evidence, that CysO specifically interacts with MoeZR and that a thiocarboxylate group is formed on CysO only in the presence of MoeZR. However, our studies also show that MoeZR has a dual role in Mycobacteria and is also involved in Moco biosynthesis. Functional complementation studies of an E. coli moeB mutant showed that MoeZR was able to complement the E. coli MoeB function only in the presence of either MoaD1 or MoaD2. This shows that MoeZR does not interact with E. coli MoaD. The amino acid sequence alignment of MoaD1, MoaD2, CysO and E. coli MoaD shows, that MoaD2 is more related to CysO than to MoaD1 (Fig. 5). Also, MoaD1 shares higher amino sequence identities to E. coli MoaD than to MoaD2. Thus, we speculate that in vivo in M. tuberculosis MoaD1 might preferentially interact with MoeBR, a speculation supported by the closer amino acid sequence identities to the E. coli congeners and the fact that both genes were simultaneously acquired by horizontal gene transfer. However, our studies also show that MoeBR is also able to interact with MoaD2. On the other hand, MoaD2 might be the more specific interaction partner to MoeZR, a speculation based on the fact that some Mycobacteria strains only contain MoeZR and MoaD2 and no additional MoaD1 copies. Our study clearly shows that MoeZR has a role in Moco biosynthesis in Mycobacteria in addition to its role in cysteine biosynthesis. Our results are also supported by the fact that the M. avium, M. smegmatis, M marinum, and M. ulcerans strains only have a MoeZR homolog and no additional MoeB-homolog (Table 3), while expressing active molybdoenzymes, as shown for M. smegmatis before [14]. Thus, even though MoeZR is more distantly related to E. coli MoeB, it is the more widely distributed MoeB-homolog in Mycobacteria. Since MoeZR can perform two roles in Moco biosynthesis and cysteine biosynthesis, this might have been more advantageous to Mycobacteria than keeping two MoeB-homologs. Our studies clearly revealed, that the role of MoeBR is restricted to Moco biosynthesis. MoeBR is unable to interact with CysO, however, it is able to interact with both MoaD1 and MoaD2. Since the Mycobacterial MoeZR and MoeBR proteins showed a higher ability to complement the E. coli MoeB function when their own MoaD congeners were present. The main difference between the E. coli and the Mycobacterial MoeB-like proteins is that both Mycobacterial congeners contain a C-terminal rhodanese-like domain. Thus, a fusion of the rhodanese-like protein to the MoeB-domain was sustained during evolution in Mycobacteria. In contrast in E. coli, IscS was shown to be the primary sulfur donor for Moco biosynthesis, transferring the sulfur to MoaD [12]. Recently, a separate rhodanese-like protein was identified in E. coli, named YnjE, which was shown to act as a mediator between the sulfurtransfer from IscS to the MoaD/MoeB complex in E. coli, making the interaction more specific [24]. Thus, in E. coli the sulfur transfer pathway is realized by several protein partners, and not by fusion proteins. The primary sulfur donor for Moco biosynthesis in Mycobacteria remains to be elucidated. However, IscS homologs were identified [25] (Table 3), which might act as the primary sulfur donor to the rhodanese-like domain, as shown for the human MOCS3 protein [26].
Table 3

Distribution of genes involved in Moco and cysteine biosynthesis in different Mycobacterium strains.

M. tuberculosis H37Rv M. bovis BCG Pasteur M. smegmatis mc2155 M. avium 104 M. marinum M M. ulcerans Agy99
moaD1 RV3112BCG_3137----
moaD2 Rv0868cBCG_0920cMSMEG_5699MAV_0997MMAR_4664MUL_0282
cysO Rv1335BCG_1397MSMEG_4906-MMAR_4063MUL_3927
moaE1 Rv3119-----
moaE2 Rv0866BCG_0918MSMEG_5701MAV_0995MMAR_4666MUL_0284
moaX Rv3323cBCG_3389c----
moeZR Rv3206cBCG_3232cMSMEG_1937MAV_4153MMAR_1352MUL_2527
moeBR Rv3116BCG_3141----
iscS Rv3025cBCG_3048cMSMEG_2357MAV_3872MMAR_1689MUL_1927
cysM Rv1336BCG_1398MSMEG_4905MAV_0444MMAR_4629MUL_0242
Figure 5

Amino acid sequence comparison of E. coli MoaD, M. tuberculosis MoaD1, M. tuberculosis MoaD2, and M. tuberculosis CysO.

Identical amino acids are boxed in black and homologous amino acids residues are shaded in grey.

Amino acid sequence comparison of E. coli MoaD, M. tuberculosis MoaD1, M. tuberculosis MoaD2, and M. tuberculosis CysO.

Identical amino acids are boxed in black and homologous amino acids residues are shaded in grey. Purification and characterization of MoeBR and MoeZR showed, that both proteins had the same secondary structure. MoeBR and MoeZR were purified in an active form which showed comparable thiosulfatecyanide sulfurtransferase activities, however, thiosulfate is most likely not the physiological sulfur source, since the Km values were unphysiological. The kcat values with thiosulfate were comparable to the ones identified for other MoeB-like proteins containing a C-terminal rhodanese-like domain, like the human yeast Uba4 [22]. We also planned to purify and characterize MoaX. MoaX is a fusion protein of MoaD and MoaE [14]. For the accurate function of MoaD, the C-terminal glycine has to be accessible for the adenylation and sulfurtransfer reaction by the MoeB-homolog and for the subsequent sulfurtransfer to cPMP in conjunction with MoaE. Williams et al. [14] showed that MoaX was able to complement both, an M. smegmatis moaD2 mutant and a moaE2 mutant, assuming that an active MPT synthase was produced. The assumption was that MoaX is cleaved in the cell and a separate and active MoaD protein is generated. Our studies show that MoaX was not able to complement the E. coli moeB mutant in conjunction with MoeBR or MoeZR, and in addition single E. coli moaD and moaE mutant strains were also not complemented by moaX (data not shown). Thus, in E. coli the system for cleavage of MoaX seems to be missing. Unfortunately, we did not succeed to express and purify MoaX for further characterization, since the majority of the protein was expressed in inclusion bodies (data not shown). So far, the role of MoaX for Mycobacteria remains unclear. Especially since only M. tuberculosis and M. bovis species have acquired a MoaX homolog. It also remains possible that MoaX has a role in the cell apart from Moco biosynthesis, however, this is only a speculation. It is not clear yet, why different Mycobacteria strains contain several homologs of genes for Moco biosynthesis. The moaA1-moaB1-moaC1-moaD1 cluster and moeB2 (coding for MoeBR) were acquired by horizontal gene transfer in M. tuberculosis and M. bovis [14]. Also, the moaA3-moaB3-moaC3-moaX gene cluster was acquired by horizontal gene transfer in these strains. Williams et al. [14] showed that the moaA1-moaD1 cluster is dispensable when grown with nitrate in the medium. Thus, the additional copies of the genes from Moco biosynthesis might have an advantage under special growth conditions, which are not necessary to maintain the general growth of Mycobacteria. Our studies show that both MoeBR and MoeZR are able to perform Moco biosynthesis. Since almost all Mycobacterium species have a MoeZR homolog, MoeZR seems to perform a dual role in the cell, the role in Moco biosynthesis in conjunction with MoaD2 and the role in cysteine biosynthesis in conjunction with CysO (Fig. 6). The role of MoeBR seems to be restricted to Moco biosynthesis and most likely it preferentially interacts with MoaD1 in the cell, since both genes have been aquired simultaneously by horizontal gene transfer. However, both MoeBR and MoeZR retained their ability to interact with both MoaD1 and MoaD2 (Fig. 6). How both processes, the biosynthesis of Moco and cysteine are regulated in the cell, has to be determined in future studies. Since L-cysteine is the likely sulfur donor for Moco biosynthesis and an L-cysteine desulfurase acts as sulfur donor to MoeZR, MoeZR might be the link for both biosynthetic pathways and could be the main switch for feedback regulation.
Figure 6

Proposed model for the role of MoeZR and MoeBR in Mycobacteria.

Functional complementation studies of an E. coli moeB strain showed that both MoeZR and MoeBR are able to interact with either MoaD1 or MoaD2. In addition, MoeZR is able to sulfurate CysO for cysteine biosynthesis, while MoeBR is not able to interact with CysO.

Proposed model for the role of MoeZR and MoeBR in Mycobacteria.

Functional complementation studies of an E. coli moeB strain showed that both MoeZR and MoeBR are able to interact with either MoaD1 or MoaD2. In addition, MoeZR is able to sulfurate CysO for cysteine biosynthesis, while MoeBR is not able to interact with CysO.

Materials and Methods

Bacterial Strains, Plasmids, Media, and Growth Conditions

The bacterial strains and plasmids used in this work are listed in Table 4. E. coli BL21(DE3) cells were used for expression of the Mycobacterial proteins. Bacterial cultures were generally grown in LB medium under aerobic conditions at 30°C. When required, 150 µg/mL ampicillin or 50 µg/mL chloramphenicol was added to the medium.
Table 4

Strains and Plasmids used in this study.

Species and strain or plasmidRelevant characteristicsSource or reference
E. coli
BL21(DE3)F- ompT hsdDB (rB-mB-) gal dcm (DE3) [28]
moeB(DE3) F- rpsL, MJ441 chlN (DE3) [10]
Plasmids
pMal_MtmoeBR pMal_MtmoeBR, EcoRI/HindIII, resulting in a N-terminal MBP-tagThis study
pSM2pMal_MbmoeZR, EcoRI/HindIII, resulting in a N-terminal MBP-tagThis study
pCO10pACYCDuet1_MbmoaD1, BamHI/NotI, resulting in a N-terminal His6-tagThis study
pCO13pACYCDuet1_MbmoaD2, BamHI/NotI, resulting in a N-terminal His6-tagThis study
pCO16pACYCDuet1_MbcysO, BamHI/NotI, resulting in a N-terminal His6-tagThis study
pSM1pACYCDuet1_MbmoaX, BamHI, resulting in a N-terminal His6-tagThis study
pMW15eBpET15b-EcmoeB, NdeI/BamHI [10]
pMW15aDpET15b-EcmoaD, NdeI/BamHI [6]

Protein Expression and purification

The clones for the expression of MoeBR and MoeZR were obtained from the EMBL in Hamburg. For coexpression of M. tuberculosis MoeZR or MoeBR, and M. bovis MoaD1, MoaD2, MoaE2, or CysO, the corresponding plasmids (Table 4) were cotransformed into E. coli BL21(DE3) cells. For overexpression of the recombinant MBP-tagged MoeBR and MoeZR proteins, 1 liter of LB medium (for proteins on the pMalC2x vector, 0.2% glucose was added) was inoculated with 20 ml overnight culture of BL21(DE3) carrying the respective plasmid and cultivated at 37°C to an optical density at 600 nm of 0.6 before protein expression was induced by addition of 100 µM isopropyl-β-D-thiogalactopyranoside. Growth was continued for 4–6 h at 30°C, and cells were harvested by centrifugation and resuspended in 100 ml of 20 mM Tris, 200 mM NaCl, 1 mM EDTA, pH 7.4. Cell lysis was achieved by several passages through a cell disrupter (Constant systems). After centrifugation (20,000× g, 20 min), the supernatant of MBP-tagged MoeBR and MoeZR was combined with 1–2 ml of amylose affinity matrix equilibrated with 20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.4. After two washing steps with 12 column volumes of 20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.4 the protein was eluted in 3 mL fractions with 20 mM Tris-HCl, 200 mM NaCl, 1 mM EDTA, 1 mM DTT, 10 mM maltose, pH 7.4. After purification all proteins were dialyzed into 100 mM Tris-HCl, 200 mM NaCl, pH 7.4 prior to use. MoeZR was further purified by size exclusion chromatography on a Superose 12 column equilibrated in 100 mM Tris, 200 mM NaCl, pH 7.4.

Functional complementation of an E. coli moeB mutant strain

For functional complementation, the E. coli moeB strain was transformed with the corresponding expression plasmids for E. coli MoeB (pMW15eB) and MoaD (pMW15aD), control, and the Mycobacterium tuberculosis MoeBR (pMal_MtMoeBR), MoeZR (pSM2) alone or for coexpression with M. bovis His6-MoaD1 (pCO10), His6-MoaD2 (pCO13), His6-CysO (pCO16), His6-MoaX (pSM1). For quantitative determination of nitrate reductase activity, the transformed E. coli cells were grown aerobically at 30°C in 5 ml of LB medium containing 15 mM nitrate. Protein expression was induced with 20 µM IPTG. Nitrate reductase activity in crude cell extracts was determined by a spectroscopic assay using benzyl viologen as described by Jones and Garland [27]. Nitrate reductase activity is related to the amount of cells measured at an O.D. at 600 nm. One unit of nitrate reductase activity is described as the production of 1 µmol of nitrite per min per O.D. 600.

Thiosulfate∶cyanide sulfurtransferase activity

Thiosulfatecyanide sulfurtransferase activities of MoeZR and MoeBR were measured by the classic colorimetric method after Sörbo [21], which is based on the absorbance of the complex formed between ferric ion and thiocyanate at 460 nm. Reaction mixtures in 100 mM Tris-acetate (pH 8.6), contained varying concentrations of sodium thiosulfate (0.5–60 mM) and varying concentrations of potassium cyanide (0.1–40 mM) in a volume of 0.5 mL. Reactions were started by the addition of the enzyme in a range of 0.5–1 µM, depending on the MoeB-like variant used. After an incubation time of 0.5–1 min at 25°C, formaldehyde (15%, 250 µL) was added to quench the reaction. Color was developed by the addition of 750 µL of ferric nitrate reagent [100 g of Fe(NO3)3×9H2O and 200 mL of 65% HNO3 per 1500 mL]. After a further incubation for 10 min, thiocyanate (complexed with iron) was quantified at 460 nm using ε = 4200 M−1×cm−1.

Electrospray Ionization MS

Aliquots (1–3 μL) of MoaD1, MoaD2, CysO purified from extracts coexpressed with MoeBR or MoeZR dissolved in 5 mM NH4OAc buffer were diluted 1∶1 with methanol followed by addition of 1–10% formic acid (final protein concentration 1–10 pmol/µL) and applied to gold-coated nanospray glass capillaries, which were placed orthogonally in front of the entrance hole of a Q-TOFmicro instrument (Micromass, Manchester, U.K.). A voltage of approximately 1000 V was applied to the capillary, and ions were separated by the time-of-flight analyzer of the mass spectrometer. Protein spectra were deconvoluted using the MaxEnt1 software package (Micromass, Manchester, UK).

CD spectroscopy

Far-UV CD spectra of 0.1 mg/mL enzyme samples were recorded in 100 mM Tris, 200 mM NaCl, pH 7.4 using a Jasco J-715 CD-spectrophotometer. The scanning mode was set step-wise, each nm a data pitch was recorded, the response time was 4 seconds and each measurement was repeated 3 times.
  28 in total

1.  Functional analysis of molybdopterin biosynthesis in mycobacteria identifies a fused molybdopterin synthase in Mycobacterium tuberculosis.

Authors:  Monique J Williams; Bavesh D Kana; Valerie Mizrahi
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

2.  Cysteine synthase (CysM) of Mycobacterium tuberculosis is an O-phosphoserine sulfhydrylase: evidence for an alternative cysteine biosynthesis pathway in mycobacteria.

Authors:  Daniel Agren; Robert Schnell; Wulf Oehlmann; Mahavir Singh; Gunter Schneider
Journal:  J Biol Chem       Date:  2008-09-16       Impact factor: 5.157

3.  Characterization of Escherichia coli MoeB and its involvement in the activation of molybdopterin synthase for the biosynthesis of the molybdenum cofactor.

Authors:  S Leimkühler; M M Wuebbens; K V Rajagopalan
Journal:  J Biol Chem       Date:  2001-07-19       Impact factor: 5.157

4.  Genetic requirements for the survival of tubercle bacilli in primates.

Authors:  Noton K Dutta; Smriti Mehra; Peter J Didier; Chad J Roy; Lara A Doyle; Xavier Alvarez; Marion Ratterree; Nicholas A Be; Gyanu Lamichhane; Sanjay K Jain; Michelle R Lacey; Andrew A Lackner; Deepak Kaushal
Journal:  J Infect Dis       Date:  2010-06-01       Impact factor: 5.226

5.  The History of the Discovery of the Molybdenum Cofactor and Novel Aspects of its Biosynthesis in Bacteria.

Authors:  Silke Leimkühler; Margot M Wuebbens; K V Rajagopalan
Journal:  Coord Chem Rev       Date:  2011-05-01       Impact factor: 22.315

6.  Sites and specificity of the reaction of bipyridylium compounds with anaerobic respiratory enzymes of Escherichia coli. Effects of permeability barriers imposed by the cytoplasmic membrane.

Authors:  R W Jones; P B Garland
Journal:  Biochem J       Date:  1977-04-15       Impact factor: 3.857

7.  O-phospho-L-serine and the thiocarboxylated sulfur carrier protein CysO-COSH are substrates for CysM, a cysteine synthase from Mycobacterium tuberculosis.

Authors:  Seán E O'Leary; Christopher T Jurgenson; Steven E Ealick; Tadhg P Begley
Journal:  Biochemistry       Date:  2008-10-09       Impact factor: 3.162

8.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

9.  Mycobacterium tuberculosis WhiB3 responds to O2 and nitric oxide via its [4Fe-4S] cluster and is essential for nutrient starvation survival.

Authors:  Amit Singh; Loni Guidry; K V Narasimhulu; Deborah Mai; John Trombley; Kevin E Redding; Gregory I Giles; Jack R Lancaster; Adrie J C Steyn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

10.  Structural, functional, and evolutionary analysis of moeZ, a gene encoding an enzyme required for the synthesis of the Pseudomonas metabolite, pyridine-2,6-bis(thiocarboxylic acid).

Authors:  Marc S Cortese; Allan B Caplan; Ronald L Crawford
Journal:  BMC Evol Biol       Date:  2002-04-23       Impact factor: 3.260

View more
  10 in total

1.  bis-Molybdopterin guanine dinucleotide is required for persistence of Mycobacterium tuberculosis in guinea pigs.

Authors:  Monique J Williams; Crystal A Shanley; Andrew Zilavy; Blas Peixoto; Claudia Manca; Gilla Kaplan; Ian M Orme; Valerie Mizrahi; Bavesh D Kana
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

Review 2.  Ubiquitin-like proteins and their roles in archaea.

Authors:  Julie A Maupin-Furlow
Journal:  Trends Microbiol       Date:  2012-11-08       Impact factor: 17.079

3.  Tularemia progression accompanied with oxidative stress and antioxidant alteration in spleen and liver of BALB/c mice.

Authors:  Miroslav Pohanka; Oto Pavlis; Branislav Ruttkay-Nedecky; Jiri Sochor; Jakub Sobotka; Jiri Pikula; Vojtech Adam; Rene Kizek
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

4.  Cleavage of the moaX-encoded fused molybdopterin synthase from Mycobacterium tuberculosis is necessary for activity.

Authors:  Nicole C Narrandes; Edith Erika Machowski; Valerie Mizrahi; Bavesh D Kana
Journal:  BMC Microbiol       Date:  2015-02-06       Impact factor: 3.605

5.  Whole transcriptomic and proteomic analyses of an isogenic M. tuberculosis clinical strain with a naturally occurring 15 Kb genomic deletion.

Authors:  Carla Duncan; Frances B Jamieson; JoLynn Troudt; Linda Izzo; Helle Bielefeldt-Ohmann; Angelo Izzo; Carolina Mehaffy
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

6.  Comparative genomics of molybdenum utilization in prokaryotes and eukaryotes.

Authors:  Ting Peng; Yinzhen Xu; Yan Zhang
Journal:  BMC Genomics       Date:  2018-09-19       Impact factor: 3.969

7.  Deciphering the Proteomic Landscape of Mycobacterium tuberculosis in Response to Acid and Oxidative Stresses.

Authors:  Eira Choudhary; Rishabh Sharma; Pramila Pal; Nisheeth Agarwal
Journal:  ACS Omega       Date:  2022-07-18

8.  AC2P20 selectively kills Mycobacterium tuberculosis at acidic pH by depleting free thiols.

Authors:  Shelby J Dechow; Garry B Coulson; Michael W Wilson; Scott D Larsen; Robert B Abramovitch
Journal:  RSC Adv       Date:  2021-06-04       Impact factor: 3.361

9.  Co-opting sulphur-carrier proteins from primary metabolic pathways for 2-thiosugar biosynthesis.

Authors:  Eita Sasaki; Xuan Zhang; He G Sun; Mei-yeh Jade Lu; Tsung-lin Liu; Albert Ou; Jeng-yi Li; Yu-hsiang Chen; Steven E Ealick; Hung-wen Liu
Journal:  Nature       Date:  2014-05-11       Impact factor: 49.962

10.  Transcriptional Response of Mycobacterium tuberculosis to Cigarette Smoke Condensate.

Authors:  Danicke Willemse; Chivonne Moodley; Smriti Mehra; Deepak Kaushal
Journal:  Front Microbiol       Date:  2021-10-15       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.